Paper - WANFANG MED ONLINE

You Position: Home > Paper

Association of HLA?DR3 and HLA?DR15 Polymorphisms with Risk of Systemic Lupus Erythematosus

( views:22, downloads:5 )

Author:: No author available

Journal Title:: Chinese Medical Journal

Issue:: 23

DOI:: 10.4103/0366?6999.246058

Key Word:: HLA-DR15;HLA-DR3;HLA-DRB1;Meta?Analysis;Systemic Lupus Erythematosus

Abstract： Background: Systemic lupus erythematosus (SLE) is an autoimmune disease under genetic control. Growing evidences support the genetic predisposition of HLA?DRB1 gene polymorphisms to SLE, yet the results are not often reproducible. The purpose of this study was to assess the association of two polymorphisms of HLA?DRB1 gene (HLA?DR3 and HLA?DR15) with the risk of SLE via a comprehensive meta?analysis. Methods: This study complied with the Preferred Reporting Items for Systematic Reviews and Meta?Analyses statement. Case-control studies on HLA?DRB1 and SLE were searched from PubMed, Elsevier Science, Springer Link, Medline, and Cochrane Library database as of June 2018. Analysis was based on the random?effects model using STATA software version 14.0. Results: A total of 23 studies were retained for analysis, including 5261 cases and 9838 controls. Overall analysis revealed that HLA?DR3 and HLA?DR15 polymorphisms were associated with the significant risk of SLE (odds ratio [OR]: 1.60, 95％ confidence interval (CI ): 1.316–1.934, P = 0.129 and OR: 1.68, 95％ CI: 1.334–2.112, P = 0.001, respectively). Subgroup analyses demonstrated that for both HLA?DR3 and HLA?DR15 polymorphisms, ethnicity was a possible source of heterogeneity. Specifically, HLA?DR3 polymorphism was not associated with SLE in White populations (OR: 1.60, 95％ CI: 1.320–1.960, P = 0.522) and HLA?DR15 polymorphism in East Asian populations (OR: 1.65, 95％ CI: 1.248–2.173, P = 0.001). In addition, source of control was another possible source for both HLA?DR3 and HLA?DR15 polymorphisms, with observable significance for HLA?DR3 in only population?based studies (OR: 1.65, 95％ CI: 1.370–1.990, P = 0.244) and for HLA?DR15 in both population?based and hospital?based studies (OR: 1.38, 95％ CI: 1.078–1.760, P = 0.123 and OR: 2.08, 95％ CI: 1.738–2.490, P = 0.881, respectively). Conclusions: HLA?DRB1 gene may be a SLE?susceptibility gene, and it shows evident ethnic heterogeneity. Further prospective validations across multiple ethnical groups are warranted.

Reference

[1]Kim, Kwangwoo,Bang, So-Young,Yoo, Dae Hyun,etc.Imputing Variants in HLA-DR Beta Genes Reveals That HLA-DRB1 Is Solely Associated with Rheumatoid Arthritis and Systemic Lupus Erythematosus[J].2016,(2).
[2]Maida Wong,Betty P. Tsao.Current topics in human SLE genetics[J].2006,28(2).
[3]Phipps ME,Chow SK,Mohd Yusuf Y,etc.HLA-A*11 and novel associations in Malays and Chinese with systemic lupus erythematosus.[J].2011,139(1).
[4]Moher, David,Liberati, Alessandro,Tetzlaff, Jennifer,etc.Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.[J].2009,339(7716).
[5]Migliorini P,Baldini C,Rocchi V,etc.Anti-Sm and anti-RNP antibodies.[J].2005,38(1).
[6]Sandling JK,Hom G,Gateva V.A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus.[J].2009,41(11).
[7]J, Zú?iga,G, Vargas-Alarcón,G, Hernández-Pacheco,etc.Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with systemic lupus erythematosus (SLE).[J].2001,2.
[8]Ghodke-Puranik, Yogita,Niewold, Timothy B..Immunogenetics of systemic lupus erythematosus: A comprehensive review[J].2015,64.
[9]Anderson N,DeCeulaer K,Dowe G,etc.HLA-DRB alleles and systemic lupus erythematosus in Jamaicans.[J].2002,95(7).
[10]Sim DL,Gaskin F,Rajagopalan G,etc.HLA-DR3 restricted T cell epitope mimicry in induction of autoimmune response to lupus-associated antigen SmD.[J].2011,37(3).
[11]Andreia, Bettencourt,Cláudia, Carvalho,Bárbara, Leal,etc.The Protective Role of HLA-DRB1(?)13 in Autoimmune Diseases.[J].2015,2015.
[12]G, Vargas-Alarcón,N, Salgado,J, Granados,etc.Class II allele and haplotype frequencies in Mexican systemic lupus erythematosus patients: the relevance of considering homologous chromosomes in determining susceptibility.[J].2001,62(8).
[13]Pineda-Tamayo R,Diaz-Gallo LM,Anaya JM,etc.Meta-analysis of HLA-DRB1 and HLA-DQB1 polymorphisms in Latin American patients with systemic lupus erythematosus.[J].2008,7(4).
[14]Furukawa, Hiroshi,Kawasaki, Aya,Oka, Shomi,etc.Human Leukocyte Antigens and Systemic Lupus Erythematosus: A Protective Role for the HLA-DR6 Alleles DRB1*13:02 and *14:03.[J].2014,9(2).
[15]Salgado N,Granados J,Lopez-Tello A,etc.Association of HLA-DRB1*16 with chronic discoid lupus erythematosus in Mexican mestizo patients.[J].2007,32(4).
[16]J D, Reveille,B O, Barger,T W, Hodge.HLA-DR2-DRB1 allele frequencies in DR2-positive black Americans with and without systemic lupus erythematosus.[J].1991,38.
[17]Sowinska, Anna,Piotrowski, Piotr,Jagodziriski, Pawel P.,etc.TNF-308 G/A polymorphism and risk of systemic lupus erythematosus in the Polish population[J].2015,25(5).
[18]Hend, Hachicha,Arwa, Kammoun,Nadia, Mahfoudh,etc.Human leukocyte antigens-DRB1*03 is associated with systemic lupus erythematosus and anti-SSB production in South Tunisia.[J].1900,12(1).
[19]Lee HS,Kim TG,Bae SC,etc.Independent association of HLA-DR and FCgamma receptor polymorphisms in Korean patients with systemic lupus erythematosus.[J].2003,42(12).
[20]Cruz, Giovanna I.,Shao, Xiaorong,Quach, Hong,etc.A Child's HLA-DRB1 genotype increases maternal risk of systemic lupus erythematosus[J].2016,74.
[21]Furnrohr BG,Harley JB,Merrill JT,etc.The genetics of systemic lupus erythematosus and implications for targeted therapy.[J].2011,70(Suppl.1).
[22]Shimane,K.,Kochi,Y.,Suzuki,A.,etc.An association analysis of HLA-DRB1 with systemic lupus erythematosus and rheumatoid arthritis in a Japanese population: Effects of *09:01 allele on disease phenotypes[J].2013,52(7).
[23]Imada, Alicia,Timoner, Branca Engel,Porto, Luis Cristovao,etc.The prevalence of HLA alleles in a lupus nephritis population[J].2018,47.
[24]F Takeuchi,S Wangkaew,G H Hong,etc.The genetic contribution of HLA-DRB5*01:01 to systemic lupus erythematosus in Thailand.[J].2013,40(2).
[25]Weber IT.,Harrison RW..Molecular Mechanics Calculations on Hiv-1 Protease with Peptide Substrates Correlate with Experimental Data[J].1996,9(8).
[26]McHugh N J.MHC class II, tumour necrosis factor\u00a0, and lymphotoxin\u00a0 gene haplotype associations with serological subsets of systemic lupus erythematosus[J].2006.
[27]Lindsay S, Uman.Systematic reviews and meta-analyses.[J].2011,20(1).
[28]Aniko Kapitany.Human Leukocyte Antigen-DRB1 and -DQB1 Genotyping in Lupus Patients with and without Antiphospholipid Syndrome[J].2009,1173.
[29]James Bentham,David L Morris,Deborah S Cunninghame Graham,etc.Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus[J].2015,47(12).
[30]Zheng HF,Han JW,Cui Y.Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus.[J].2009,41(11).
[31]M Rudwaleit,M Tikly,K Gibson,etc.HLA class II antigens associated with systemic lupus erythematosus in black South Africans.[J].1995,54(8).
[32]Nageen, Hussain,Ghazala, Jaffery,Anjum Nasim, Sabri,etc.HLA association in SLE patients from Lahore-Pakistan.[J].2011,11(1).